1. What is this study about?
The study aims to evaluate the effectiveness of use of a personal, self-management, ‘smartphone’ application (app) to achieve target serum urate concentrations in people with gout. We will compare the effectiveness of two versions of the app in improving adherence to urate lowering therapy and subsequently achieving a target plasma urate ≤ 0.36 mmol/L in participating patients.
2. Who is eligible to participate?
We are looking for GPs who:
- Are based in Australia;
- Have seen gout patients within the past year.
3. What is involved?
If you decide to participate in the research study, you will be requested to complete and return a consent form and to help recruit your gout patients into the study (ideally around 3 patients). Once a patient has been , you will be asked to see them for routine gout check-ups and pathology services for blood tests at their enrolment and then at the 6 and 12-month time points.
We do not expect that there will be any risks or costs associated with taking part in this study.
Upon your participation, your practice will receive a gift card ($300) to acknowledge your valuable contribution to the research.
4. Professional Development Activity
This study is also part of an optional professional development activity for the 2017-2019 triennium, which has been approved by both the RACGP QI&CPD Program for a total of 40 category 1 points and the ACRRM’s PDP for 30 PRPD points.
For more information click here.
5. How do I participate?
You can download a copy of the GP consent form here, and return it to our team by contacting us below.
Or you can contact our team on the following details for more information:
|Name||Dr Matthew Coleshill|
|Position||Postdoctoral Research Fellow|
|Telephone||1800 931 544|